CD44, a cell surface receptor for hyaluronic acid (HA), osteopontin (OPN) and many other ligands has been shown to play a key role in prostate cancer (PCa) metastasis, migration, and invasion [6, 11, 12]. Here, CD44 is linked to prostate carcinoma.